The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive
Clinical trial NCT06495541 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06495541
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2026-07-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.